Steven Georgian
Foot & Ankle Surgery · Lucedale, MSNPI 1699237461
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (59.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Mid-atlantic Surgical Systems, LLC accounts for 61.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $1,307 and has fallen 85.9% since, to $185 in 2025.
Across 30 payments — averaging $136.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$2K
- Paragon 28, Inc.$614
- Stryker$421
- Smith+Nephew$167
- Abbott$131
- Paratek Pharmaceuticals, Inc.$70
- plus $186 from 5 others
What the payments were for
- Travel & lodging$38810%
- Food & beverage$1,28631%
- Education$2,40959%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 7 | $2,493 |
| Paragon 28, Inc. | 4 | $614 |
| Stryker | 6 | $421 |
| Smith+Nephew | 2 | $167 |
| Abbott | 1 | $131 |
| Paratek Pharmaceuticals, Inc. | 4 | $70 |
| Medtronic | 1 | $67 |
| Bayer | 2 | $59 |
| Organogenesis Inc. | 1 | $26 |
| Kerecis Limited | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few foot & ankle surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 161 | $3,296 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 95 | $3,169 |
| Triamcinolone Acetonide | 34 | $488 |
| Mupirocin | 72 | $462 |
| Doxycycline Hyclate | 68 | $414 |
| Naproxen | 90 | $335 |
| Clobetasol Propionate | 15 | $311 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $269 |
| Cephalexin | 33 | $98 |
| Meloxicam | 18 | $20 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lucedale
- Marion LundOxford$46K
- John KoskoHattiesburg$40K
- Lori ReedJackson$28K
- Jeremy AdamsTupelo$17K
- Daniel RossFlowood$16K
- Judith SmithBiloxi$8K
- Jeffery VanyperenAmory$6K
- Ashley BlackwellJackson$2K
- Richard CukeljCleveland$2K
- Stanitia DavisJackson$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.